Navigation Links
Essure Procedure Now Covered by Medicaid in California
Date:5/14/2008

MOUNTAIN VIEW, Calif., May 14 /PRNewswire-FirstCall/ -- Conceptus, Inc. (Nasdaq: CPTS) developer of the Essure(R) procedure, the first and only non-incisional permanent birth control method available, today reported that Medi-Cal, California's state fee-for-service Medicaid program, is now covering the Essure procedure. Low-income or disabled women in California now have a safe and effective permanent female birth control option that does not require the general anesthesia, incisions or long recovery period of traditional tubal ligation.

"We are very happy that Medi-Cal has completed its review of the safety and efficacy of the Essure device and has established coverage for this procedure," said California Assembly Speaker pro Tem Sally Lieber. "This is a great day for the women of California covered by Medicaid, who will now be able to avoid the risks and long recovery times associated with traditional tubal ligation surgery."

The Essure procedure is now a covered procedure for Medi-Cal beneficiaries that are 21 years of age or older. Physicians may perform the Essure procedure in the physician's office, the ambulatory surgery center or the hospital outpatient department. Medi-Cal is expected to pay $2,282 as a global fee for an in-office procedure. This coverage decision impacts approximately 3.8 million Californians.

Coverage of the Essure procedure enables state Medicaid programs to provide a safe, convenient and economical choice for preventing pregnancies. In addition, the shorter recovery time-typically one day as compared with four to six days for the traditional laparoscopic procedure-means a faster return to work or home responsibilities. California joins 45 other states now covering the Essure procedure for women enrolled in Medicaid. Conceptus has yet to receive Medicaid decisions for the Essure procedure in Arizona, Nebraska, North Dakota, Utah and Washington.

"We continue to provide compelling information on the costs and benefits of the Essure procedure to those few remaining state Medicaid programs that have not given a coverage decision, and to lobby for improved payment in those states with poor reimbursement," commented Mark Sieczkarek, president and chief executive officer of Conceptus. "This positive coverage decision from Medi-Cal is an important step in our efforts to make Essure available to women from all socioeconomic backgrounds."

About the Essure Procedure

The Essure procedure, approved by the FDA in 2002, is a permanent birth control procedure that replaces tubal ligation for women. In the comfort of a physician's office and in about 10 minutes, the soft micro-inserts are placed into the Fallopian tubes through the cervix eliminating the need for incisions. Once in place, the device is designed to elicit tissue growth in and around the micro-insert to form an occlusion or blockage in the Fallopian tubes.

The Essure confirmation test is performed three months after the procedure to confirm that the micro-inserts are in the correct location, the tubes are blocked and that the woman can discontinue temporary birth control. The Essure procedure is 99.80% effective and is the first and only FDA approved female sterilization procedure to have zero pregnancies in clinical trials.

About Conceptus

Conceptus, Inc. manufactures and markets the Essure Permanent Birth Control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation, which is currently the leading form of birth control worldwide. The availability of the Essure procedure in the U.S. is expected to open up a market currently occupied by incisional tubal ligation and vasectomy, which combined account for over 1 million procedures annually.

Additional information about the Essure procedure is available at http://www.essure.com or by calling the Essure Information Center at 1-877-ESSURE1. Additional information about Conceptus is available at http://www.conceptus.com or by calling 1-877-ESSURE2.

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Discussions regarding the continued availability of Medicaid coverage, and the Company's ability to obtain Medicaid coverage from additional states, among other matters discussed in this release, may differ significantly from the discussion of such matters in the forward-looking statements. Such differences may be based upon factors such as strategic planning decisions by management, re-allocation of internal resources, decisions by insurance companies, scientific advances by third parties, and introduction of competitive products, as well as those factors set forth in the Company's most recent Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q, and other filings with the Securities and Exchange Commission.

Contact Information:

Ashley Biever

310-577-7870 x 111

ashley.biever@fischerhealth.com


'/>"/>
SOURCE Conceptus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Aspirin at Bedtime Lowers Blood Pressure
2. High Blood Pressure, Cholesterol Associated With Eye Disease
3. High Blood Pressure Still Slipping Past Doctors
4. Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life, Including Pregnancy
5. Double duty: Loss of protective heart failure protein causes high blood pressure
6. Simple Steps Lead to Better Blood Pressure Control
7. Blood pressure killing the worlds workers while banks and drug firms stand idle
8. High blood pressure still sneaking past doctors, Stanford study shows
9. Study Reveals Women Feeling Growing Financial Pressures on Family Life
10. High Blood Pressure May Be Buffer Against Headaches
11. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/25/2017)... CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music video ... above footage and sound in the timeline and write in the lyrics to any song. ... flying back out. Each line of the text can be added modularly for optimal control. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... With a heatwave currently bearing down on Northern ... out at the pool. Being swimsuit ready is easy with laser hair removal. , ... again can be a burdensome routine when all you want to do is get out, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. ... 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine ... visits to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation ... significant harm to people with all chronic conditions, including mental illnesses, while increasing ... place the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: